<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Maglakelidze M</submitter><funding>National Institute for Health Research (NIHR)</funding><pagination>e056902</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9511586</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>12(9)</volume><pubmed_abstract>&lt;h4>Objectives&lt;/h4>To assess the feasibility of delivering a culturally tailored pulmonary rehabilitation (PR) programme and conducting a definitive randomised controlled trial (RCT).&lt;h4>Design&lt;/h4>A two-arm, randomised feasibility trial with a mixed-methods process evaluation.&lt;h4>Setting&lt;/h4>Secondary care setting in Georgia, Europe.&lt;h4>Participants&lt;/h4>People with symptomatic spirometry-confirmed chronic obstructive pulmonary disease recruited from primary and secondary care.&lt;h4>Interventions&lt;/h4>Participants were randomised in a 1:1 ratio to a control group or intervention comprising 16 twice-weekly group PR sessions tailored to the Georgian setting.&lt;h4>Primary and secondary outcome measures&lt;/h4>Feasibility of the intervention &lt;i>and&lt;/i> RCT were assessed according to: study recruitment</pubmed_abstract><journal>BMJ open</journal><pubmed_title>Feasibility of a pulmonary rehabilitation programme for patients with symptomatic chronic obstructive pulmonary disease in Georgia: a single-site, randomised controlled trial from the Breathe Well Group.</pubmed_title><pmcid>PMC9511586</pmcid><funding_grant_id>16/137/95</funding_grant_id><pubmed_authors>Maglakelidze M</pubmed_authors><pubmed_authors>Sitch AJ</pubmed_authors><pubmed_authors>Maglakelidze N</pubmed_authors><pubmed_authors>Jolly K</pubmed_authors><pubmed_authors>Chkhaidze I</pubmed_authors><pubmed_authors>Chi C</pubmed_authors><pubmed_authors>Enocson A</pubmed_authors><pubmed_authors>Kurua I</pubmed_authors><pubmed_authors>Gale NK</pubmed_authors><pubmed_authors>Adab P</pubmed_authors><pubmed_authors>Dickens AP</pubmed_authors><pubmed_authors>Redden-Rowley K</pubmed_authors><pubmed_authors>Jordan RE</pubmed_authors><pubmed_authors>Farley A</pubmed_authors><pubmed_authors>Rai K</pubmed_authors><pubmed_authors>Chkhaidze N</pubmed_authors><pubmed_authors>Stelmach R</pubmed_authors><pubmed_authors>Turner AM</pubmed_authors><pubmed_authors>Jowett S</pubmed_authors><pubmed_authors>Cheng KK</pubmed_authors><pubmed_authors>Martins S</pubmed_authors><pubmed_authors>Stavrikj K</pubmed_authors><pubmed_authors>Gogvadze K</pubmed_authors><pubmed_authors>Adams R</pubmed_authors><pubmed_authors>Maglakelidze T</pubmed_authors><pubmed_authors>Cooper B</pubmed_authors><pubmed_authors>Correia-de-Sousa J</pubmed_authors><pubmed_authors>Beadle H</pubmed_authors><pubmed_authors>Williams S</pubmed_authors></additional><is_claimable>false</is_claimable><name>Feasibility of a pulmonary rehabilitation programme for patients with symptomatic chronic obstructive pulmonary disease in Georgia: a single-site, randomised controlled trial from the Breathe Well Group.</name><description>&lt;h4>Objectives&lt;/h4>To assess the feasibility of delivering a culturally tailored pulmonary rehabilitation (PR) programme and conducting a definitive randomised controlled trial (RCT).&lt;h4>Design&lt;/h4>A two-arm, randomised feasibility trial with a mixed-methods process evaluation.&lt;h4>Setting&lt;/h4>Secondary care setting in Georgia, Europe.&lt;h4>Participants&lt;/h4>People with symptomatic spirometry-confirmed chronic obstructive pulmonary disease recruited from primary and secondary care.&lt;h4>Interventions&lt;/h4>Participants were randomised in a 1:1 ratio to a control group or intervention comprising 16 twice-weekly group PR sessions tailored to the Georgian setting.&lt;h4>Primary and secondary outcome measures&lt;/h4>Feasibility of the intervention &lt;i>and&lt;/i> RCT were assessed according to: study recruitment</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Sep</publication><modification>2026-06-06T20:23:41.851Z</modification><creation>2025-04-05T17:55:30.902Z</creation></dates><accession>S-EPMC9511586</accession><cross_references><pubmed>36153030</pubmed><doi>10.1136/bmjopen-2021-056902</doi></cross_references></HashMap>